Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study

H Lind, A-C Waldenström, G Dunberger, M al-Abany, E Alevronta, K-A Johansson, C Olsson, T Nyberg, U Wilderäng, G Steineck, E Åvall-Lundqvist, H Lind, A-C Waldenström, G Dunberger, M al-Abany, E Alevronta, K-A Johansson, C Olsson, T Nyberg, U Wilderäng, G Steineck, E Åvall-Lundqvist

Abstract

Background: We surveyed the occurrence of physical symptoms among long-term gynaecological cancer survivors after pelvic radiation therapy, and compared with population-based control women.

Methods: We identified a cohort of 789 eligible gynaecological cancer survivors treated with pelvic radiation therapy alone or combined with surgery in Stockholm or Gothenburg, Sweden. A control group of 478 women was randomly sampled from the Swedish Population Registry. Data were collected through a study-specific validated postal questionnaire with 351 questions concerning gastrointestinal and urinary tract function, lymph oedema, pelvic bones and sexuality. Clinical characteristics and treatment details were retrieved from medical records.

Results: Participation rate was 78% for gynaecological cancer survivors and 72% for control women. Median follow-up time after treatment was 74 months. Cancer survivors reported a higher occurrence of symptoms from all organs studied. The highest age-adjusted relative risk (RR) was found for emptying of all stools into clothing without forewarning (RR 12.7), defaecation urgency (RR 5.7), difficulty feeling the need to empty the bladder (RR 2.8), protracted genital pain (RR 5.0), pubic pain when walking indoors (RR 4.9) and erysipelas on abdomen or legs at least once during the past 6 months (RR 3.6). Survivors treated with radiation therapy alone showed in general higher rates of symptoms.

Conclusion: Gynaecological cancer survivors previously treated with pelvic radiation report a higher occurrence of symptoms from the urinary and gastrointestinal tract as well as lymph oedema, sexual dysfunction and pelvic pain compared with non-irradiated control women. Health-care providers need to actively ask patients about specific symptoms in order to provide proper diagnostic investigations and management.

Figures

Figure 1
Figure 1
Flow chart for study population.
Figure 2
Figure 2
Treatment modality dependent on diagnosis. Abbreviations: Surg=surgery; EBRT=external beam radiation therapy; BT=brachytherapy; chemo=chemotherapy.

References

    1. al-Abany M, Helgason AR, Cronqvist AK, Lind B, Mavroidis P, Wersäll P, Lind H, Qvanta E, Steineck G (2005) Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. Int J Radiat Oncol Biol Phys 61: 1035–1044
    1. Andreyev HJ (2007) Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol (R Coll Radiol) 19: 790–799
    1. Andreyev J (2005) Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut 54: 1051–1054
    1. Anscher MS (2010) Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist 15: 350–359
    1. Beesley V, Janda M, Eakin E, Obermair A, Battistutta D (2007) Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer 109: 2607–2614
    1. Bentzen SM (2006) Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 6: 702–713
    1. Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, Ten Haken RK, Yorke ED (2010) Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 76: S3–S9
    1. Bergmark K, vall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G (1999) Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med 340: 1383–1389
    1. Bergmark K, vall-Lundqvist E, Dickman PW, Henningsohn L, Steineck G (2006) Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer 16: 1130–1139
    1. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, Eckberg K, Lloyd S, Purl S, Blendowdki C, Goodman M, Barnicle M, Stewart I, Mchale M, Bonomi P, Kaplan E, Taylor S, Thomas CR, Harris J (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11: 570–579
    1. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van der Steen-Banasik E, Beerman H, van Lent M (2001) The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial. Int J Radiat Oncol Biol Phys 51: 1246–1255
    1. Denham JW, Hauer-Jensen M (2002) The radiotherapeutic injury--a complex ‘wound’. Radiother Oncol 63: 129–145
    1. Denton AS, Maher EJ (2003) Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database Syst Rev (1): CD003750 Art. no.
    1. Dörr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61: 223–231
    1. Dunberger G, Lind H, Steineck G, Waldenström AC, Nyberg T, Al-Abany M, Nyberg U, Åvall-Lundqvist E (2010) Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls. Eur J Cancer 46: 606–616
    1. Eifel PJ, Levenback C, Wharton JT, Oswald MJ (1995) Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32: 1289–1300
    1. Elliott SP, Malaeb BS (2011) Long-term urinary adverse effects of pelvic radiotherapy. World J Urol 29: 35–41
    1. Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC (2005) Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 23: 7428–7436
    1. Grigsby PW, Russell A, Bruner D, Eifel P, Koh WJ, Spanos W, Stetz J, Stitt JA, Sullivan J (1995) Late injury of cancer therapy on the female reproductive tract. Int J Radiat Oncol Biol Phys 31: 1281–1299
    1. Hauer-Jensen M, Wang J, Boerma M, Fu Q, Denham JW (2007) Radiation damage to the gastrointestinal tract: mechanisms, diagnosis, and management. Curr Opin Support Palliat Care 1: 23–29
    1. International Commission on Radiation Units and Measurements (1993) Prescribing, recording and reporting photon beam therapy. ICRU Report 50
    1. Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D (2003) Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 56: 937–949
    1. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, Pearlman A, Maiman MA, Bell JG (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92: 744–751
    1. Korfage IJ, Essink-Bot ML, Mols F, van de Poll-Franse L, Kruitwagen R, van Ballegooijen M (2009) Health-related quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys 73: 1501–1509
    1. Marks LB, Carroll PR, Dugan TC, Anscher MS (1995) The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31: 1257–1280
    1. McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157: 940–943
    1. Mornex F, Pavy JJ, Denekamp J, Bolla M (1997) [Scoring system of late effects of radiations on normal tissues: the SOMA-LENT scale]. Cancer Radiother 1: 622–668
    1. Nout RA, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Stenfert Kroese MC, van Bunningen BN, Smit VT, Nijman HW, van den Tol PP, Creutzberg CL (2009) Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol 27: 3547–3556
    1. Park SY, Bae DS, Nam JH, Park CT, Cho CH, Lee JM, Lee MK, Kim SH, Park SM, Yun YH (2007) Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer 110: 2716–2725
    1. Pieterse QD, Maas CP, ter Kuile MM, Lowik M, van Eijkeren MA, Trimbos JB, Kenter GG (2006) An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer. Int J Gynecol Cancer 16: 1119–1129
    1. Putta S, Andreyev HJ (2005) Faecal incontinence: a late side-effect of pelvic radiotherapy. Clin Oncol (R Coll Radiol) 17: 469–477
    1. Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH (1995) Overview. Late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31: 1041–1042
    1. Sinistrero G, Sismondi P, Rumore A, Zola P (1993) Analysis of complications of cervix carcinoma treated by radiotherapy using the Franco-Italian glossary. Radiother Oncol 26: 203–211
    1. Small Jr W, Mell LK, Anderson P, Creutzberg C, De Los Santos J, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ (2008) Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys 71: 428–434
    1. Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK (1993) The european organization for research and treatment of cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res 2: 287–295
    1. Steineck G, Bergmark K, Henningsohn L, al-Abany M, Dickman PW, Helgason A (2002) Symptom documentation in cancer survivors as a basis for therapy modifications. Acta Oncol 41: 244–252
    1. Steineck G, Hunt H, Adolfsson J (2006) A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods. Acta Oncol 45: 421–429
    1. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13: 176–181
    1. Waldenström AC, Olsson C, Wilderäng U, Dunberger G, Lind H, Al-Abany M, Palm A, vall-Lundqvist E, Johansson KA, Steineck G (2010) Pain and mean absorbed dose to the pubic bone after radiotherapy among gynecological cancer survivors. Int J Radiat Oncol Biol Phys 80: 1171–1180

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する